Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: Safety & Feasibility of PERIsign System in Demonstrating Involuntary Muscle Defense as a Sign of Peritonitis in Subjects With Appendicitis [NA]

View source ↗

Summary

This completed early-phase clinical trial evaluated the safety and feasibility of the PERIsign System to detect involuntary muscle defense as a sign of peritoni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: STB INN AB | Conditions: Appendicitis Acute, Appendicitis | NA | Status: COMPLETED